iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/20143386/
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 May;31(5):786-97.
doi: 10.1002/hbm.20905.

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI

Liana G Apostolova  1 , Paul M Thompson, Amity E Green, Kristy S Hwang, Charleen Zoumalan, Clifford R Jack Jr, Danielle J Harvey, Ronald C Petersen, Leon J Thal, Paul S Aisen, Arthur W Toga, Jeffrey L Cummings, Charles S Decarli
Affiliations
Clinical Trial

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI

Liana G Apostolova et al. Hum Brain Mapp. 2010 May.

Erratum in

  • Hum Brain Mapp. 2010 Dec;31(12):2015

Abstract

We applied the hippocampal radial atrophy mapping technique to the baseline and follow-up magnetic resonance image data of 169 amnestic mild cognitive impairment (MCI) participants in the imaging arm of the Alzheimer's Disease Cooperative Study MCI Donepezil/Vitamin E trial. Sixty percent of the subjects with none to mild hippocampal atrophy rated with the visual medial temporal atrophy rating scale (MTA score < 2) and 33.8% of the subjects with moderate to severe (MTA > or = 2) hippocampal atrophy converted to Alzheimer's disease (AD) during 3-year follow-up. MTA > or = 2 showed a trend for greater left sided hippocampal atrophy versus MTA < 2 groups at baseline (P(corrected) = 0.08). Higher MTA scores were associated with progressive atrophy of the subiculum and the CA1-3 subregions. The MTA < 2 group demonstrated significant bilateral atrophy progression at follow-up (left P(corrected) = 0.008; right P(corrected) = 0.05). Relative to MTA < 2 nonconverters, MTA < 2 converters showed further involvement of the subiculum and CA1 and additional involvement of CA2-3 at follow-up. Right CA1 atrophy was significantly associated with conversion to dementia (for 1 mm greater right CA1 radial distance subjects had 50% reduced hazard for conversion). Greater CA1 and subicular atrophy can be demonstrated early and is predictive of future conversion to AD, whereas CA2-3 involvement becomes more evident as the disease progresses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Baseline MTA < 2 versus MTA ≥ 2 comparison. Top row—schematic representation of the hippocampal subfields based on Duvernoy [Duvernoy,1988] and West and Gunderson [1990]. Middle row—3D statistical maps showing areas where MTA ≥ 2 subjects show greater atrophy relative to MTA < 2 at baseline (significant areas appear in red and white; blue denotes P=0.1 or greater). Bottom row—ratio maps showing the quantitative between‐group differences (in %).
Figure 2
Figure 2
MTA subgroup comparisons. The top row maps show areas where significant between‐group differences were observed in the specific comparisons. The bottom row maps show the quantitative between‐group differences (in %). [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 3
Figure 3
Correlation between MTA rating and hippocampal radial distance at baseline. The top row shows a schematic representation of the hippocampal subfields based on Duvernoy [1988] and West and Gunderson [1990]. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 4
Figure 4
MTA < 2 MCIc versus MCInc comparison. Top row—schematic representation of the hippocampal subfields based on Duvernoy [1988] and West and Gunderson [1990]. Middle rows—3D statistical maps of the baseline and follow‐up MCIc versus MCInc comparisons. Bottom rows—quantitative between‐group difference between MCIc and MCInc at baseline and follow‐up (in %). [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 5
Figure 5
These maps illustrate the absolute spread of hippocampal atrophy in MCIc from baseline (top row) to follow‐up (second row). The bottom row 3D maps show the interim 3‐year hippocampal atrophy in the MCIc group alone (in %). [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM ( 2006a): 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 129 ( Pt 11): 2867–2873. - PubMed
    1. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM ( 2006b): Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63: 693–699. - PubMed
    1. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ ( 2008): Subregional hippocampal atrophy predicts future decline to Alzheimer's dementia in cognitively normal subjects. Neurobiol Aging (epub ahead of print). doi: 10.1016/j.neurobiolaging. 2008.08.008. - PMC - PubMed
    1. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, Mlodzik B, de Leon MJ, Miller DC ( 1995): Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia 6: 205–210. - PubMed
    1. Bobinski M, Wegiel J, Tarnawski M, Bobinski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM ( 1997): Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56: 414–420. - PubMed

Publication types